Technical Analysis for FULC - Fulcrum Therapeutics, Inc.

Grade Last Price % Change Price Change
C 9.44 -0.21% -0.02
FULC closed down 0.21 percent on Thursday, March 28, 2024, on 82 percent of normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Boomer Sell Setup Bearish Swing Setup 0.00%
50 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -0.21%
Crossed Above 50 DMA Bullish -0.21%
Inside Day Range Contraction -0.21%
Wide Bands Range Expansion -0.21%
Oversold Stochastic Weakness -0.21%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 12 hours ago
Possible Inside Day about 12 hours ago
Up 1% about 13 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Down 2 % about 15 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-HbF, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and b-thalassemia. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Disease Disability Disorders Dystrophy Muscular Dystrophy Hemoglobin Progressive Infancy Sickle Cell Disease Thalassemia Facioscapulohumeral Muscular Dystrophy

Is FULC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.7
52 Week Low 2.25
Average Volume 676,614
200-Day Moving Average 5.70
50-Day Moving Average 9.26
20-Day Moving Average 10.53
10-Day Moving Average 9.82
Average True Range 0.74
RSI (14) 44.13
ADX 33.53
+DI 19.90
-DI 21.33
Chandelier Exit (Long, 3 ATRs) 11.49
Chandelier Exit (Short, 3 ATRs) 11.06
Upper Bollinger Bands 12.23
Lower Bollinger Band 8.84
Percent B (%b) 0.18
BandWidth 32.21
MACD Line -0.05
MACD Signal Line 0.23
MACD Histogram -0.2705
Fundamentals Value
Market Cap 583.61 Million
Num Shares 61.8 Million
EPS -1.66
Price-to-Earnings (P/E) Ratio -5.69
Price-to-Sales 208.91
Price-to-Book 2.14
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.01
Resistance 3 (R3) 10.01 9.81 9.92
Resistance 2 (R2) 9.81 9.67 9.82 9.88
Resistance 1 (R1) 9.63 9.58 9.53 9.63 9.85
Pivot Point 9.43 9.43 9.39 9.44 9.43
Support 1 (S1) 9.25 9.29 9.15 9.25 9.03
Support 2 (S2) 9.05 9.20 9.06 9.00
Support 3 (S3) 8.87 9.05 8.97
Support 4 (S4) 8.87